Hello, Fool! | Login | Signup | My Fool
Oct 6, 2008 10:01 PM ET | Feedback | Site Changes | Help
A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.
View Ticker Page (HNAB)
Results 1 - 5 of 5 : 1
Recs
greenie001 (57.77) Submitted: 2/22/07 10:38 AM : Start Price: $5.03 HNAB Score: -61.82
Oversold
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
fullwealth (94.40) Submitted: 3/05/07 12:21 PM : Start Price: $3.93 HNAB Score: -62.89
ride the index back up
Joe1962 (< 20) Submitted: 3/12/07 1:05 PM : Start Price: $4.04 HNAB Score: 62.05
Into development, and with many competitiors, a risky stock. With the change of directors, Im sure it will take a bit of time to get things rolling. The phase clinicals take time. If something gets into phase three, and eventually passes, then the st...
RBBioContest06 (29.37) Submitted: 5/31/06 10:46 PM : Start Price: $9.11 HNAB Score: -76.71
Picked by CLICK101
bioman100 (28.75) Submitted: 8/24/06 10:05 PM : Start Price: $7.38 HNAB Score: -74.05
prostate drug in development, oral navelbine, good pipeline.
Terms & Conditions
RSS Headlines
Fool UK